Form 4: InnovAge Director Richard Zoretic Boosts Stake with Over 42,000 Share Purchases

InnovAge Holding Corp. Director Richard C. Zoretic has significantly increased his direct beneficial ownership in the company through a series of common stock purchases totaling 42,715 shares over three days in late May 2025.

Summary

• InnovAge Holding Corp. (INNV) Director Richard C. Zoretic acquired a total of 42,715 shares of common stock through open market purchases between May 28, 2025, and May 30, 2025.
• On May 28, 2025, Mr. Zoretic purchased 20,000 shares at a weighted average price of $4.06 per share, bringing his direct beneficial ownership to 45,779 shares.
• On May 29, 2025, an additional 14,265 shares were acquired at a weighted average price of $4.04 per share, increasing his direct beneficial ownership to 60,044 shares.
• On May 30, 2025, Mr. Zoretic bought 8,450 shares at a weighted average price of $4.08 per share, resulting in a total direct beneficial ownership of 68,494 shares.
• The reported prices are weighted averages, with individual transaction prices ranging from $3.97 to $4.21 for the May 28 purchase, $3.97 to $4.05 for the May 29 purchase, and $3.95 to $4.20 for the May 30 purchase.

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to significant insider buying by a director, which typically signals strong confidence in the company's future and valuation.

Positives

• The significant increase in share ownership by a director indicates strong insider confidence in the company's future prospects and valuation.
• The purchases were made at varying price points, suggesting a belief in the stock's value across a range, and potentially a long-term investment horizon.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or outlook. It solely reports insider trading activity.

Industry Context

Insider buying, particularly by a director, is often interpreted by the market as a positive signal, suggesting that those with intimate knowledge of the company believe its stock is undervalued or that positive developments are anticipated. This activity in InnovAge (a healthcare services provider, specifically PACE programs) could reflect confidence in the company's operational improvements, regulatory environment, or growth strategy within the senior care sector.

Stakeholder Impact

• Shareholders: May view the director's increased stake as a positive indicator of future stock performance and management's belief in the company's value, potentially leading to increased investor confidence.

Key Dates

Recommendation

Keywords

InnovAge Holding Corp., INNV, Form 4, insider trading, stock purchase, director, beneficial ownership, common stock, equity acquisition